Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we will assume that you are happy to receive all cookies and you will not see this message again. Click 'Find out more' for information on how to change your cookie settings.

Dr Damien Barnette, one of the Postdoctoral Research Scientists here in the department has recently published new data in the journal JCI Insight, iRhom2-mediated proinflammatory signalling regulates heart repair following myocardial infarction.

When the heart undergoes injury, such as following a heart attackan immediate response is the infiltration of immune cells of which one important sub-type are macrophages. These are thought to come in two distinct “flavours”- early “proinflammmatory” (or M1), which mop up dead and dying cells, followed by “reparative” (M2) macrophages, which help remodel the heart and contribute to patching the area of injury with a scar.

By looking at the injured hearts in mice that lack secretion of a key inflammatory molecule called TNF-alpha from their macrophages, Dr Barnette and colleagues revealed an unexpected link between the two immune cell phases in response to injury.

The dampening of pro-inflammatory signalling had a direct, knock-on effect on scar formation, whereby the mutant mice had less stable scars, poor heart function and reduced survival.

This suggests that there is a gradient of immune cell responses which is not restricted to the two “flavours”, and that downstream repair of a heart attack by scar formation is inextricably linked to the early pro-inflammatory immune cell response. This has important implications for designing strategies to modulate inflammation and repair as a combined therapy with restoring lost cardiovascular tissue after heart attack.

This work was done in collaboration with Professor Paul RileyDr Thomas CahillMs Mala Gunadasa-Rohling, Professor Carolyn Carr, Professor Matthew Freeman (Dunn School) and was supported by the British Heart Foundation

To find out more about the research that goes on at DPAG similar to this, visit the Riley Research Group webpage.

Similar stories

Reducing fat in the diabetic heart could improve recovery from heart attack

New research from the Heather Group has shown that in type 2 diabetes an overload of lipids reduces the heart’s ability to generate energy during a heart attack, decreasing chances of recovery.

The brain’s one-sided teaching signals

A new study by the Lak group reveals a novel facet of dopamine signalling during visual decision making.

Fellowship awarded to Huriye Atilgan to enhance our understanding of value-based decision-making

Congratulations are in order for Postdoctoral Research Scientist Dr Huriye Atilgan who has been awarded a prestigious Sir Henry Wellcome Postdoctoral Fellowship funded by the Wellcome Trust.

The future of stroke treatment

A team of international collaborators including DPAG's Dr Mootaz Salman has been researching a promising new therapeutic for the treatment of strokes and other brain injuries.

New review reveals proof of concept for an anti-obesity immunotherapy

The Domingos lab has published a new opinion piece in Science investigating the implications of a Memorial Sloan Kettering Cancer Center study that lays the foundations for a potential new anti-obesity treatment in the form of targeting adipose tissue-resident macrophages.